drug
azenosertib
Phase 2updated 3mo agoby $ZNTL Zentalis Pharmaceuticals, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying azenosertib
- phase3A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- phase2A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- phase1A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- phase1A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma
- phase2A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
- phase2A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
- phase1A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
- EP1Targeted Pathway Inhibition in Patients With Pancreatic Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that